Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins.

Antiviral Res · 2022 · PMC9075985 · PMID 35533779

Europe PMC DOI

hedged sentence

0.0782

closest p · 1.6× alpha

0.0782

boldest claim

The sentences

did not reach statistical significanceP = 0.0782so close (0.05 < p ≤ 0.1)

6 a); however, these did not reach statistical significance with the full-length group being the closest in the nasal wash sample (P = 0.0782, Mann-Whitney test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.